Moneycontrol PRO
HomeNewsBusinessStocksAccumulate Pidilite Ind; target of Rs 225: Dolat Capital

Accumulate Pidilite Ind; target of Rs 225: Dolat Capital

Dolat Capital is bullish on Pidilite Industries and has recommended accumulate rating on the stock with a target of Rs 225 in its October 31, 2012 research report.

November 01, 2012 / 13:46 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Dolat Capital is bullish on Pidilite Industries and has recommended accumulate rating on the stock with a target of Rs 225 in its October 31, 2012 research report.


    “Pidilite Industires’s consumer bazaar business grew by 19% (Volume - 11% and value - 8%). Industrial segment grew by 3.5% (Q2FY12 growth was at 18%) was driven by volumes. Export segment continues to be impacted due to slowdown in Europe market. We expect this to improve in coming quarters as base effect kicks in (Q3FY12 - Industrial business declined by 2%). Consumer bazaar business grew by 19% (Volume - 11% and value - 8%).Industrial segment grew by 3.5% (Q2FY12 growth was at 18%) was driven by volumes. Export segment continues to be impacted due to slowdown in Europe market. We expect this to improve in coming quarters as base effect kicks in (Q3FY12 - Industrial business declined by 2%).”


    “Company indicated that in some of the product categories which are focusing on Industrial and Infrastructure project there are signs of slowdown. Construction chemicals product which targets the Infrastructure and large project segment is witnessing slowdown. VAM prices have now stabilised after a correction in Q1FY13. It currently stands at around $950-$1000/ton. Gross margin improvement was on account of 1) price hike and 2) softening of VAM prices. Ad-spends which was lower in Q1FY13 witnessed some increase in investment. Ad-spends to sales ratio during the quarter stood at 4% v/s 2.2% in Q2FY12. International business reported revenue of Rs 887mn up 7.3% (5.7% in terms of constant currency) and EBITDA loss of Rs 14.6mn.”


    “We continue to remain positive on Pidilite Industries. Likely clarity on elastomer project in Jan 2013 will eliminate the overhang on the stock. We believe Dr. Fixit brand in the construction chemical has a huge potential and could be the next Fevicol. The stock trades at 25x FY13E EPS of Rs 7.6 and 19x FY14E EPS of Rs 9.8. We recommend accumulate with a price target of Rs 225,” says Dolat Capita; research report.


    Shares held by Mutual Funds/UTI


    Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    To read the full report click on the attachment

    first published: Nov 1, 2012 01:39 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347